Sanjeev Slehria, MD, Prateek Sharma, MD

Disclosures

Curr Opin Gastroenterol. 2003;19(4) 

In This Article

Conclusions

In the past year we have made major strides in our knowledge of this premalignant lesion. Recent studies have shed light on the epidemiology of Barrett, including clinical and endoscopic factors associated with HGD or esophageal adenocarcinoma and various biomarkers that would identify patient subsets with low and high risk for cancer progression. This will eventually have significant implications for the screening, surveillance, and treatment of the disease. Advanced endoscopic therapies including mucosectomy or photodynamic therapy may be emerging options in patients with intraepithelial neoplasia.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....